487 related articles for article (PubMed ID: 17020533)
1. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung KF; Caramori G; Adcock IM
Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
[TBL] [Abstract][Full Text] [Related]
3. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
4. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
7. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
[TBL] [Abstract][Full Text] [Related]
8. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
Barnes PJ
Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
[TBL] [Abstract][Full Text] [Related]
10. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
Fuso L; Mores N; Valente S; Malerba M; Montuschi P
Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy in asthma--fixed or variable dosing in different patients?
Lötvall J
Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
[TBL] [Abstract][Full Text] [Related]
13. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
Mansfield LE
Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
Chung KF; Adcock IM
Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
[TBL] [Abstract][Full Text] [Related]
15. Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review.
Solidoro P; Patrucco F; Bagnasco D
Expert Rev Respir Med; 2019 Nov; 13(11):1087-1094. PubMed ID: 31498714
[No Abstract] [Full Text] [Related]
16. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
17. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
Postma DS; Kerstjens HA; ten Hacken NH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):203-15. PubMed ID: 18500509
[TBL] [Abstract][Full Text] [Related]
19. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
Petite SE
Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
[TBL] [Abstract][Full Text] [Related]
20. Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.
Mapel DW; Roberts MH
Drugs; 2014 May; 74(7):737-55. PubMed ID: 24797158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
